CU kidney specialist named in insider trading case By Shira Poliak After speaking with Bomback, a Massachusetts hedge fund manager invested $800,000 in the pharmaceutical company that manufactures the drug Bomback was studying. Read more about CU kidney specialist named in insider trading case 3 comments Add new comment
